Pharmaceutical processing with supercritical carbon dioxide.
Replacement of traditional solvents with "environmentally benign" carbon dioxide is receiving increased attention in pharmaceutical processing. Among the reported applications, particle formation with dense carbon dioxide and the "clean" synthesis of drug compounds using carbon dioxide as a reaction medium hold immense potential for large-scale application in the pharmaceutical industry. This paper provides an overview of these rapidly emerging technologies along with examples of the wide variety of relatively contaminant-free pharmaceutical compounds that have been processed via these technologies on a laboratory scale. Challenges facing successful implementation in practice include demonstration of continuous production and harvesting of particles with desired and reproducible product characteristics. Mathematical models aimed at a better fundamental understanding of the underlying thermophysical phenomena are essential for rational design and scale-up of these technologies.
Subramaniam
B
B
Department of Chemical and Petroleum Engineering, and Center for Drug Delivery Research, University of Kansas, Lawrence 66045, USA.
Rajewski
R A
RA
Snavely
K
K
D002245:Carbon Dioxide / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D003460:Crystallization; D008956:Models, Chemical; D012997:Solvents
D012997:Solvents; D002245:Carbon Dioxide